Product Information
XCOPRI 250 MG DAILY DOSE PACK is a brand product labeled by SK Life Science, Inc., priced at $21.3688 per EA under NDC 71699010456. Its NADAC has been published 168 times since Jul 19, 2023.
FDA first approved this application on Mar 10, 2020.
Manufacturer
SK Life Science, Inc.NDC
71699010456
Classification
Brand
Dosage Form
KIT
Route
ORAL
Effective Date
9/23/2026
Approval Type
New Drug (NDA)
FDA Application
NDA212839FDA Approved
3/10/2020
On Market Since
4/30/2021
Price Statistics
The NADAC for XCOPRI 250 MG DAILY DOSE PACK has been published 168 times since Jul 19, 2023, and over the history we have for it it has risen 13.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $21.3688 per EA |
|---|---|
| All-time high | $21.3872 (Jul 15, 2026) |
| All-time low | $18.8213 (Jul 19, 2023) |
| 52-week high | $21.3872 |
| 52-week low | $20.7623 |
| Median price | $20.7623 |
| Average price | $20.4269 |
| Largest weekly change | +6.0% (Jan 3, 2024) |
| Weeks tracked | 168 |
| Tracking since | Jul 19, 2023 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 82% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
SK Life Science, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
cenobamate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of XCOPRI 250 MG DAILY DOSE PACK?
The current National Average Drug Acquisition Cost (NADAC) for XCOPRI 250 MG DAILY DOSE PACK, manufactured by SK Life Science, Inc., is $21.3688 per EA (NDC 71699010456), effective Sep 30, 2026.
How has the price of XCOPRI 250 MG DAILY DOSE PACK changed over time?
Over the history we have for it, the NADAC for XCOPRI 250 MG DAILY DOSE PACK has risen 13.5%. It has been tracked across 168 weekly CMS publications since Jul 19, 2023.
What are the highest and lowest recorded NADAC prices for XCOPRI 250 MG DAILY DOSE PACK?
Since Jul 19, 2023, the NADAC for XCOPRI 250 MG DAILY DOSE PACK has ranged from a low of $18.8213 (Jul 19, 2023) to a high of $21.3872 (Jul 15, 2026), with a median of $20.7623 per EA.
Are there cheaper alternatives to XCOPRI 250 MG DAILY DOSE PACK?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, XCOPRI 12.5-25 MG TITRATION PK, is $3.9104 per EA — about 82% below XCOPRI 250 MG DAILY DOSE PACK.
Who manufactures XCOPRI 250 MG DAILY DOSE PACK?
XCOPRI 250 MG DAILY DOSE PACK (NDC 71699010456) is labeled by SK Life Science, Inc., and CMS classifies it as a brand product.